Pharmacological identification of vascular smooth muscle β-adrenoceptors and clarification. of1heir physiological roles
血管平滑肌β-肾上腺素受体的药理学鉴定及其生理作用的阐明。
基本信息
- 批准号:18590242
- 负责人:
- 金额:$ 2.34万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2006
- 资助国家:日本
- 起止时间:2006 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
β-Adrenoceptors ((β-ARs) are now classified into three subtypes : β1, β2 and (β3. Of these three subtypes, β3-AR was first identified in fat tissue and its distribution and role in smooth muscles were not well known. However, we have recently found that (β3-AR is abundantly present in gastrointestinal smooth muscles and plays the key role in their relaxant responses to endogenous catecholamines. In the present study, we investigated the expression and post-receptor mechanisms of β3-AR as well as non-β3-ARs ((β1- and β2-ARs) in rat aortic smooth muscle for our better understating of the vascular smooth muscle β-ARs, and we obtained the following new findings and/or established experimental conditions.1. We established the evaluation system to detect β-AR-mediated vascular smooth muscle relaxation.2. We found that isoprenaline (ISO)-induced relaxation is mediated through propranolol (Prop)-sensitive β-AR and Prop-insensitive β-AR.3. Based on the rank order of the relaxant potencies of three catecholamines and the pA2 values of subtype-selective β-AR antagonists (atenolol and ICI-118,551) against ISO, we found that Prop-sensitive β-AR is mainly β2-AR in thoracic aorta and it is β1-AR in abdominal aorta.4. Based on the, pA2 value of bupranolol against ISO, we found that Prop-insensitive β3-AR is mainly β3-AR in both thoracic and abdominal aortae.5. We found that mRNAs and receptor proteins corresponding to each β-AR are expressed in the vascular smooth muscles used in the above mechanical studies.6. We found that β3-AR-mediated vascular relaxation is trigged by new molecular mechanisms (cAMP-independent mechanisms and contribution of voltage-dependent potassium channel).
肾上腺素能受体(β-ars,β-AR)分为β1、β2和β3三种亚型。在这三种亚型中,β3-AR最先在脂肪组织中被发现,但其在平滑肌中的分布和作用尚不清楚。然而,我们最近发现(β-3-AR)在胃肠道平滑肌中大量存在,并在其对内源性儿茶酚胺的松弛反应中发挥关键作用。在本研究中,我们研究了β3-AR和非β3-AR((β1-和β2-AR))在大鼠主动脉平滑肌中的表达及其受体后机制,以期更好地了解血管平滑肌β-AR,我们获得了以下新发现和/或建立了实验条件。结论:1.建立了检测β-AR介导的血管平滑肌舒张性的评价体系。我们发现异丙肾上腺素引起的松弛是通过心得安敏感的β-AR和心得安不敏感的β-AR介导的。根据三种儿茶酚胺的舒张效价和选择性β-AR亚型拮抗剂(阿替洛尔和ICI-118,551)的PA2值,我们发现β-AR在胸主动脉以β-2-AR为主,在腹主动脉以β-1-AR为主。根据丁普洛尔对ISO的PA2值,我们发现在胸主动脉和腹主动脉中,对Prop不敏感的β3-AR主要是β3-AR。我们发现与每个β-AR相对应的mRNAs和受体蛋白在上述力学研究中使用的血管平滑肌中都有表达。我们发现β3-AR介导的血管松弛是由新的分子机制(cAMP非依赖性机制和电压依赖性钾通道的贡献)触发的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The β-adrenoceptor subtypes in aortic smooth muscle
主动脉平滑肌中的β-肾上腺素受体亚型
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Tanaka;Y.;Koike;K
- 通讯作者:K
β_3-Adrenoceptors and drug discovery
β_3-肾上腺素受体和药物发现
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Koike;K.;Michikawa;H.;Tanaka;Y
- 通讯作者:Y
Different changes of plasma membrane β-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol
- DOI:10.1016/j.lfs.2007.06.003
- 发表时间:2007-07-12
- 期刊:
- 影响因子:6.1
- 作者:Horinouchi, Takahiro;Morishima, Shigeru;Muramatsu, Ikunobu
- 通讯作者:Muramatsu, Ikunobu
β-Adrenoceptor mechanisms in rat aortic smooth muscle : subtypes and molecular mechanisms of relaxant responses
大鼠主动脉平滑肌β-肾上腺素受体机制:松弛反应的亚型和分子机制
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Miyagawa;M.;Matsushita;M.;Michikawa;H.;Tanaka;Y.;Koike;K
- 通讯作者:K
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KOIKE Katsuo其他文献
KOIKE Katsuo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KOIKE Katsuo', 18)}}的其他基金
Study of properties of high and low affinity binding sites in beta-adrenoceptors
β-肾上腺素受体高亲和力和低亲和力结合位点特性的研究
- 批准号:
02671015 - 财政年份:1990
- 资助金额:
$ 2.34万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
An image-based AI tool to identify stiffness- or age-related mechanotransduction abnormalities in vascular smooth muscle cells
一种基于图像的人工智能工具,用于识别血管平滑肌细胞中与硬度或年龄相关的机械转导异常
- 批准号:
BB/Y513994/1 - 财政年份:2024
- 资助金额:
$ 2.34万 - 项目类别:
Research Grant
Systems Genetics of Vascular Smooth Muscle Phenotypes
血管平滑肌表型的系统遗传学
- 批准号:
10771623 - 财政年份:2023
- 资助金额:
$ 2.34万 - 项目类别:
Vascular Smooth Muscle Protein Quality Control and Aortic Aneurysm Formation
血管平滑肌蛋白质量控制与主动脉瘤形成
- 批准号:
10714562 - 财政年份:2023
- 资助金额:
$ 2.34万 - 项目类别:
Biomimetic Vascular Matrix for Vascular Smooth Muscle Cell Mechanobiology and Pathology
用于血管平滑肌细胞力学生物学和病理学的仿生血管基质
- 批准号:
10586599 - 财政年份:2023
- 资助金额:
$ 2.34万 - 项目类别:
Obscurin-Deficient Breast Epithelia Generate Secreted Factors that Prime Lung Vascular Smooth Muscle Cell Pre-metastatic Microenvironment Formation
暗蛋白缺陷的乳腺上皮细胞产生分泌因子,促进肺血管平滑肌细胞转移前微环境的形成
- 批准号:
10749467 - 财政年份:2023
- 资助金额:
$ 2.34万 - 项目类别:
Intrinsic stiffness of aortic vascular smooth muscle cell in the development of hypertension
高血压发展过程中主动脉血管平滑肌细胞的固有硬度
- 批准号:
10910432 - 财政年份:2023
- 资助金额:
$ 2.34万 - 项目类别:
Vascular smooth muscle cell ferroptosis and abdominal aortic aneurysm
血管平滑肌细胞铁死亡与腹主动脉瘤
- 批准号:
10733477 - 财政年份:2023
- 资助金额:
$ 2.34万 - 项目类别:
Vascular Smooth Muscle Lysyl Oxidase Mediated Increase in Vessel Stiffness and its Effect on Rho-Kinase Mechanosensors
血管平滑肌赖氨酰氧化酶介导的血管硬度增加及其对 Rho 激酶机械传感器的影响
- 批准号:
10768089 - 财政年份:2023
- 资助金额:
$ 2.34万 - 项目类别:
The role of PAR2 and HuR in programming atherosclerotic vascular smooth muscle cells
PAR2和HuR在动脉粥样硬化血管平滑肌细胞编程中的作用
- 批准号:
10749319 - 财政年份:2023
- 资助金额:
$ 2.34万 - 项目类别:
MicroRNA elucidation of the pathogenesis of vascular smooth muscle cell calcification from postprandial hyperglycemia
MicroRNA阐明餐后高血糖血管平滑肌细胞钙化的发病机制
- 批准号:
23K06912 - 财政年份:2023
- 资助金额:
$ 2.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)